Publications by authors named "J Callhoff"
Article Synopsis
- The study aimed to evaluate the prevalence of mental health disorders like depression and anxiety in individuals with inflammatory rheumatic diseases (iRMD) such as rheumatoid arthritis, ankylosing spondylitis, and others, compared to those with osteoarthritis (OA).
- Data from over 101,000 participants in the German National Cohort were analyzed, using various self-reported assessments and cognitive tests.
- Results showed that people with iRMD had higher rates of depression (26%) and anxiety (15%) compared to those with OA, with women being more affected than men, but cognitive function was similar between both groups.
Background: Rheumatology in Germany is facing major challenges. The need for rheumatological care is increasing and can no longer be met in some regions for capacity reasons. Too many people with an inflammatory rheumatic disease (IRD) have to forego appropriate care or receive it too late.
View Article and Find Full Text PDFWith the new ICD-11 developed by the WHO and translated into German for use in Germany by the Federal Institute for Drugs and Medical Devices, the German healthcare system is facing a change that is more than a simple change of a medical coding system. The ICD-11 modernises the coding system, for example, by including new, separate health conditions such as sleep-wake disorders and conditions related to sexual health, thus making the corresponding diseases more visible. The ICD-11 is more precise than the ICD-10: it allows cross-referencing between diagnoses, symptoms, functionality and locations and partially abandons the strict hierarchy of the ICD-10.
View Article and Find Full Text PDFIn the National database (NDB) of the German regional collaborative arthritis centres, annual data on the rheumatological care of patients with inflammatory rheumatic diseases have been collected since 1993. This first annual report presents current cross-sectional data on medication and patient-reported outcomes gathered in 2022.
View Article and Find Full Text PDFBackground: Studies on prevalence rates of mental comorbidities in patients with juvenile idiopathic arthritis (JIA) have reported varying results and provided limited information on related drugs. The purpose of this study was to determine the prevalence of selected mental health diagnoses and the range of associated drug prescriptions among adolescents and young adults (AYA) with JIA compared with general population controls.
Findings: Nationwide statutory health insurance data of the years 2020 and 2021 were used.